跳至主要内容
临床试验/NCT04153955
NCT04153955撤回3 期

Earlier Mobilization Post Acute Thrombectomy

Brian Silver0 个研究点开始时间: 2023年8月1日最近更新:
适应症

试验速览

阶段
3 期
状态
撤回
发起方
主要终点
90 Day Modified Rankin Scale (mRS) score

研究概览

简要总结

This is a phase III trial trying to determine whether 12-hour bed rest following thrombectomy for ischemic stroke is non-inferior to 24-hour bed rest by measure of outcomes on the modified Rankin Scale (mRS) at 90 days post bed rest.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Assessors blind to the subject's treatment/arm will do the evaluations at 90 days

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Received thrombectomy (may have also received intravenous tPA) for a diagnosis of acute ischemic stroke
  • TICI 2b/2c/3 score following thromectomy
  • Patient and/or Legally Authorized Representative provide consent

排除标准

  • TICI 0/1/2a score following thrombectomy
  • Venous thromboembolism present at symptom onset
  • Pneumonia present at symptom onset
  • STEMI at symptom onset
  • Positive troponins at symptom onset according to local values
  • Bone fracture at symptom onset
  • Intubation anticipated or occurred
  • Symptomatic intracranial hemorrhage (defined as increase in NIHSS by 4 points or more accompanied by PH2 hemorrhage on imaging) at the time of screening.
  • Pre-screening systolic blood pressure < 110 mmHg
  • Resting pulse oximetry < 92% (with or without supplemental oxygen)
  • Neurological worsening (defined as NIHSS increase of 4 points compared to initial score) prior to screening.
  • Baseline modified Rankin Scale score > 2
  • Known Pregnancy
  • Patient not anticipated to survive 3 months
  • Patient not anticipated to follow-up at 3 months

结局指标

主要结局

90 Day Modified Rankin Scale (mRS) score

时间窗: 90 days post bed rest

Proportion of patients with a modified Rankin Scale score (min 0, max 5 with 0 being the best outcome) of 0-2 at 90 days

次要结局

  • Venous Thromboembolism(Duration of hospitalization stay, average 5 days)
  • Pneumonia(Duration of hospitalization stay, average 5 days)
  • Readmission(90 days post bed rest)
  • Neurological Worsening(Duration of hospitalization stay, average 5 days)
  • Length of Stay(Duration of hospitalization stay, average 5 days)

研究者

发起方
Brian Silver
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Brian Silver

Principal Investigator

University of Massachusetts, Worcester

相似试验